Main Finding: A phase I trial supported the safety and feasibility of repeated intracranial infusions of B7-H3 CAR T cells for DIPG. Concept: B7-H3 is an immunoregulatory protein expressed on the ...
1The University of Texas MD Anderson Cancer Center, Houston, TX. Search for other works by this author on: ...
1The Nairobi Hospital, Nairobi, Kenya.
1Stanford University, Stanford, CA.
Search for other works by this author on: ...
1Stanford University, Stanford, CA.
1UT MD Anderson Cancer Center, Houston, TX.
1MD Anderson Cancer Center, Houston, TX.
Search for other works by this author on: ...
Antibody-drug conjugates (ADCs) are transforming the treatment landscape in metastatic bladder cancer, but the role of ADCs in localized disease is uncertain. Radiation is a central component of ...
Clin Cancer Res (2025) 31 (2_Supplement): P008.
1Stanford University, Stanford, CA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback